<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A single positive laboratory test among those exploring the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is not associated with <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> and does not identify patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>On the other hand, more than one laboratory test positive, and in particular <z:hpo ids='HP_0000001'>all</z:hpo> three tests positive, is strongly associated to <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> and identifies high risk patients </plain></SENT>
<SENT sid="2" pm="."><plain>Triple positivity is in fact related to the presence of a specific anti-Î²2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-Domain I) antibody, also able to prolong coagulation tests </plain></SENT>
<SENT sid="3" pm="."><plain>Monoclonal antibodies against Domain I with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">Anticoagulant</z:chebi> activity might be candidate material for standardization of antiphospholipid assays </plain></SENT>
<SENT sid="4" pm="."><plain>Much work remains to be done in this field </plain></SENT>
</text></document>